Lutz Lingnau - Net Worth and Insider Trading
Lutz Lingnau Net Worth
The estimated net worth of Lutz Lingnau is at least $47,259 dollars as of 2024-05-15. Lutz Lingnau is the Director of Nektar Therapeutics and owns about 26,700 shares of Nektar Therapeutics (NKTR) stock worth over $47,259. Details can be seen in Lutz Lingnau's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lutz Lingnau has not made any transactions after 2019-09-27 and currently still holds the listed stock(s).
Transaction Summary of Lutz Lingnau
Lutz Lingnau Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lutz Lingnau owns 1 companies in total, including Nektar Therapeutics (NKTR) .
Click here to see the complete history of Lutz Lingnau’s form 4 insider trades.
Insider Ownership Summary of Lutz Lingnau
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTR | Nektar Therapeutics | 2019-09-27 | director |
Lutz Lingnau Latest Holdings Summary
Lutz Lingnau currently owns a total of 1 stock. Lutz Lingnau owns 26,700 shares of Nektar Therapeutics (NKTR) as of September 27, 2019, with a value of $47,259.
Latest Holdings of Lutz Lingnau
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NKTR | Nektar Therapeutics | 2019-09-27 | 26,700 | 1.77 | 47,259 |
Holding Weightings of Lutz Lingnau
Lutz Lingnau Form 4 Trading Tracker
According to the SEC Form 4 filings, Lutz Lingnau has made a total of 2 transactions in Nektar Therapeutics (NKTR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Nektar Therapeutics is the sale of 3,000 shares on September 27, 2019, which brought Lutz Lingnau around $53,520.
Insider Trading History of Lutz Lingnau
- 1
Lutz Lingnau Trading Performance
Lutz Lingnau Ownership Network
Lutz Lingnau Owned Company Details
What does Nektar Therapeutics do?
Who are the key executives at Nektar Therapeutics?
Lutz Lingnau is the director of Nektar Therapeutics. Other key executives at Nektar Therapeutics include SVP & General Counsel Mark Andrew Wilson , Chief R&D Officer Jonathan Zalevsky , and director & President & CEO Howard W Robin .
Nektar Therapeutics (NKTR) Insider Trades Summary
Over the past 18 months, Lutz Lingnau made no insider transaction in Nektar Therapeutics (NKTR). Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 137,918 shares made by Howard W Robin , a net sale of 62,098 shares made by Jonathan Zalevsky , and a net sale of 46,514 shares made by Mark Andrew Wilson .
In summary, during the past 3 months, insiders sold 92,653 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 92,653 shares. During the past 18 months, 332,610 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 332,610 shares.
Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nektar Therapeutics Insider Transactions
Lutz Lingnau Mailing Address
Above is the net worth, insider trading, and ownership report for Lutz Lingnau. You might contact Lutz Lingnau via mailing address: 15 Indian Hollow Road, Mendham Nj 07945.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
